Related Experiment Video
Updated: Jun 1, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
EGFR genomic alterations in cancer: prognostic and predictive values
Giuseppe Bronte1, Marianna Terrasi, Sergio Rizzo
1Department of Surgical and Oncological Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy.
Frontiers in Bioscience (Elite Edition)
|May 31, 2011
Summary
Epidermal growth factor receptor (EGFR) genomic alterations are crucial in various cancers. This review examines EGFR alterations as prognostic and predictive factors for targeted cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The epidermal growth factor receptor (EGFR) plays a significant role in the development and progression of numerous human cancers.
- EGFR is a validated target for antineoplastic therapies, with several EGFR-targeted drugs in clinical use or under investigation.
Purpose of the Study:
- To review preclinical and clinical data on EGFR genomic alterations.
- To evaluate the prognostic and predictive value of these alterations in cancer treatment.
Main Methods:
- Comprehensive literature search for studies on EGFR genomic alterations (mutations, gene copy number).
- Analysis of data regarding EGFR protein expression, gene mutations, and gene copy number.
- Synthesis of preclinical and clinical findings.
Main Results:
- EGFR protein expression data inform the selection of monoclonal antibodies in colorectal cancer.
- EGFR gene mutations guide the use of tyrosine kinase inhibitors in lung cancer.
- EGFR gene copy number is an emerging factor under investigation.
Conclusions:
- EGFR genomic alterations are important prognostic and predictive biomarkers.
- Understanding these alterations is key for optimizing targeted cancer therapy selection and patient outcomes.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...